Journal
GUT
Volume 56, Issue 10, Pages 1333-1336Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/gut.2006.115402
Keywords
-
Categories
Ask authors/readers for more resources
Exciting new results from a genetic study in humans and functional studies in mice have pinpointed interleukin 23 (IL23) and its receptor as a key pathway in the pathogenesis of inflammatory bowel disease (IBD). These findings reveal a hitherto unappreciated role for the IL23 axis in intestinal inflammation and may open new avenues for development of therapeutic strategies in IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available